← All trials
NCT04575064
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 29, 2020
- Primary completion
- Mar 31, 2022
- Completion date
- Nov 30, 2022
- First posted
- Oct 5, 2020
- Last posted
- Oct 5, 2020
- Enrollment
- 400
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Klinikum Bremen-MitteLead sponsor
- University of GoettingenSponsor investigator
- Gottfried Wilhelm Leibniz Universität HannoverOverall official - principal investigator
- University of BremenCollaborator
- World Health OrganizationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.